Validation of response-biomarkers for chemo- and targeted-therapy

We validate response-biomarkers for chemo- and targeted-therapy using cell culture models and clinical sample biobanks for breast and ovarian cancer.


Used technologies:

  • Cell culture
  • Cell proliferation and viability assays
  • RNA interference
  • RT-PCR
  • Immunhistochemistry
  • FACS
  • Cell invasion assays
  • Next generation sequencing